Clinical trials
Active, not recruiting Phase 2 trials in India
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
35 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 3 |
| 2021 | 2 |
| 2022 | 5 |
| 2023 | 6 |
| 2024 | 5 |
| 2025 | 5 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 35 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 4 |
| Janssen Research & Development, LLC | 3 |
| Sanofi | 3 |
| GlaxoSmithKline | 2 |
| Novartis Pharmaceuticals | 2 |
| Alumis Inc | 1 |
| Bayer | 1 |
| Beeline Medicines Corporation | 1 |
| Bharat Biotech International Limited | 1 |
| CanariaBio Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Autoimmune Diseases | 3 |
| Colitis, Ulcerative | 3 |
| Connective Tissue Diseases | 3 |
| Breast Neoplasms | 2 |
| Carcinoma | 2 |
| Carcinoma, Non-Small-Cell Lung | 2 |
| Idiopathic Pulmonary Fibrosis | 2 |
| Immune System Diseases | 2 |
| Lupus Erythematosus, Systemic | 2 |
| Scleroderma, Diffuse | 2 |
Trials
Showing 1 to 25 of 35. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.